Glioblastoma (GBM) is the most common form of brain cancer in adults. Glioblastoma is extremely aggressive, with disease recurring in virtually all patients and a median survival rate of ~8 months following recurrence. The currently approved standard of care has not changed in over a decade, and eligible patients are recommended to seek treatment by… Continue reading Lorem Ipsum 3
Glioblastoma (GBM) is the most common form of brain cancer in adults. Glioblastoma is extremely aggressive, with disease recurring in virtually all patients and a median survival rate of ~8 months following recurrence. The currently approved standard of care has not changed in over a decade, and eligible patients are recommended to seek treatment by… Continue reading Lorem Ipsum 2
Glioblastoma (GBM) is the most common form of brain cancer in adults. Glioblastoma is extremely aggressive, with disease recurring in virtually all patients and a median survival rate of ~8 months following recurrence. The currently approved standard of care has not changed in over a decade, and eligible patients are recommended to seek treatment by… Continue reading Lorem Ipsum
Glioblastoma (GBM) is the most common form of brain cancer in adults. Glioblastoma is extremely aggressive, with disease recurring in virtually all patients and a median survival rate of ~8 months following recurrence. The currently approved standard of care has not changed in over a decade, and eligible patients are recommended to seek treatment by… Continue reading lOREM
Glioblastoma (GBM) is the most common form of brain cancer in adults. Glioblastoma is extremely aggressive, with disease recurring in virtually all patients and a median survival rate of ~8 months following recurrence. The currently approved standard of care has not changed in over a decade, and eligible patients are recommended to seek treatment by… Continue reading Hello world!
